SR9009
SR9009
SR9009 (pronounced as S-R-Nine-Thousand-Nine) is a synthetic Rev-ErbA ligand which is taken orally. This compound is often mistakenly marketed as a Selective Androgen Receptor Modulator (SARM), but it is actually a Stenabolic agonist of Rev-ErbA.
Etymology
The term SR9009 is derived from the initials of the research institute, Scripps Research, where it was developed, and the number 9009 is a sequential identifier.
Usage
SR9009 is used in the field of medicine and pharmacology for research purposes. It is believed to have potential benefits in enhancing endurance, reducing anxiety, and lowering cholesterol levels. However, it is important to note that these benefits are yet to be confirmed in human trials.
Related Terms
- Rev-ErbA: A group of proteins that are part of the nuclear receptor family of intracellular transcription factors.
- SARMs: Selective Androgen Receptor Modulators, a type of therapeutic compound, which have similar properties to anabolic agents, but with reduced androgenic properties.
- Stenabolic: A term often used interchangeably with SR9009, although it is technically a brand name for the compound.
See Also
External links
- Medical encyclopedia article on SR9009
- Wikipedia's article - SR9009
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski